• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by SRX Health Solutions Inc.

    8/14/25 3:13:31 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $SRXH alert in real time by email
    NT 10-Q 1 formnt10-q.htm NT 10-Q

     

     

     

        OMB APPROVAL
       

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

    NOTIFICATION OF LATE FILING

    OMB Number: 3235-0058

    Expires: August 31, 2025

    Estimated average burden

    hours per response................ 2.50

        SEC FILE NUMBER
         
        CUSIP NUMBER

     

    (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K  
      ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

     

     

    For Period Ended:

    June 30, 2025  

     

    ☐Transition Report on Form 10-K
    ☐Transition Report on Form 20-F
    ☐Transition Report on Form 11-K
    ☐Transition Report on Form 10-Q

     

      For the Transition Period Ended:    

     

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

     

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

    PART I — REGISTRANT INFORMATION

     

    SRx Health Solutions Inc.

     

    Full Name of Registrant

     

    Better Choice Company Inc.

     

    Former Name if Applicable

     

    12400 Race Track Road

     

    Address of Principal Executive Office (Street and Number)

     

    Tampa, Florida 33626

     

    City, State and Zip Code

     

    SEC 1344 (01-19) Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.

     

    Board of Governors of the Federal Reserve System OMB Number 7100-0091 Approval expires February 28, 2026

     

     

     

     
     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    (a)The reason described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;
    ☒(b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
    (c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III — NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    The Registrant has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended June 30, 2025 by the prescribed due date because it requires additional time to finalize its financial statements to be included in such Form 10-Q.

     

    PART IV — OTHER INFORMATION

     

    (1)Name and telephone number of person to contact in regard to this notification

     

    Carolina Martinez   813   599-7956
    (Name)   (Area Code)   (Telephone Number)

     

    (2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
      
    (3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    The Company anticipates that the earnings statements included in the Form 10-Q for the period ended June 30, 2025, will reflect a significant change in results of operations compared to the corresponding period in the prior fiscal year. The change is primarily attributable to the completion of a reverse merger in April 2025, as well as certain non-recurring charges and developments affecting the Company’s legacy operations.

     

    2 of 3
     

     

    SRx Health Solutions Inc.

     

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date 8 /14/2025   By

     

    INSTRUCTION: The Form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the Form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the Form.

     

      ATTENTION  
         
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
         

     

    GENERAL INSTRUCTIONS

     

    1.This Form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities Exchange Act of 1934.
      
    2.One signed original and four conformed copies of this Form and amendments thereto must be completed and filed with the Securities and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and Regulations under the Act. The information contained in or filed with the Form will be made a matter of public record in the Commission files.
      
    3.A manually signed copy of the Form and amendments thereto shall be filed with each national securities exchange on which any class of securities of the registrant is registered.
      
    4.Amendments to the notifications must also be filed on Form 12b-25 but need not restate information that has been correctly furnished. The Form shall be clearly identified as an amended notification.
      
    5.Electronic filers. This form shall not be used by electronic filers unable to timely file a report solely due to electronic difficulties. Filers unable to submit a report within the time period prescribed due to difficulties in electronic filing should comply with either Rule 201 or Rule 202 of Regulation S-T (§232.201 or §232.202 of this chapter) or apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T (§232.13(b) of this Chapter).
      
    6.Interactive data submissions. This Form shall not be used by electronic filers with respect to the submission or posting of an Interactive Data File (§232.11 of this chapter). Electronic filers unable to submit or post an Interactive Data File within the time period prescribed should comply with either Rule 201 or 202 of Regulation S-T (§232.201 and §232.202 of this chapter).

     

    3 of 3

     

    Get the next $SRXH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRXH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRXH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SRx Health Solutions Signed a Letter of Intent to Acquire the Assets of Royal Uranium

    TAMPA, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) ("SRx Health" or the "Company"), a leading global health and wellness company, today announced that is has signed a non-binding Letter of Intent to purchase 100% of the assets of Royal Uranium Inc., a leading uranium royalty business with a portfolio spanning Canada, Colombia, Argentina and Namibia. The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive transaction agreements. Following the closing of this potential transaction, the Company intends to adopt a new corporate name and new ticker symbol, reflecting its expanded mission to combin

    8/18/25 7:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Announces the Cancellation of Approximately 18.8 Million Shares of its Capital Stock

    TAMPA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that further to the previously disclosed grant of an Initial Order under the federal Companies' Creditors Arrangement Act by the Ontario Superior Court of Justice to the Company's Canadian subsidiary SRx Health Solutions (Canada), Inc. ("SRx Canada") and certain of its subsidiaries, it has canceled approximately 18.8 million shares of its capital stock. The cancellation was made pursuant to a Settlement, Share Forfeiture and Mutual Release Agreement (the "Settlement Agreement") between the Company and certain of the founders an

    8/14/25 7:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    SEC Filings

    View All

    SEC Form DEF 14C filed by SRX Health Solutions Inc.

    DEF 14C - SRx Health Solutions, Inc. (0001471727) (Filer)

    8/18/25 12:25:17 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form NT 10-Q filed by SRX Health Solutions Inc.

    NT 10-Q - SRx Health Solutions, Inc. (0001471727) (Filer)

    8/14/25 3:13:31 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

    8/14/25 2:03:30 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Vora Adesh Anil claimed ownership of 325,279 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:57:50 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    New insider Sohi Davender claimed ownership of 99,038 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:56:51 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    New insider Conway Simon Alexander Malcolm claimed ownership of 50,664 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:55:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Announces Management and Board Changes

    TAMPA, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced the appointment of current President, Kent Cunningham, as CEO, and current CEO, Adesh Vora, as Vice Chairman effective immediately. About SRx Health Solutions, Inc. SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry kn

    7/15/25 9:47:55 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Financials

    Live finance-specific insights

    View All

    SRx Health Solutions Announces First Quarter 2025 Financial Results

    EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port

    5/15/25 4:05:00 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET

    TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025 and provide a business update. Conference Call and Webcast Information:Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern TimeLive Call: 1-844-825-9789 or 1-412-317-5180Webcast:  https://srxhealth.com/events-and-presentations/ For interested individuals unable to join the conference call, the webcast replay of the call will

    5/6/25 8:45:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples